Neuroimmune Interactions in Fetal Alcohol Spectrum Disorders: Potential Therapeutic Targets and Intervention Strategies.

Fetal alcohol spectrum disorders (FASD) are a set of abnormalities caused by prenatal exposure to ethanol and are characterized by developmental defects in the brain that lead to various overt and non-overt physiological abnormalities. Growing evidence suggests that in utero alcohol exposure induces functional and structural abnormalities in gliogenesis and neuron-glia interactions, suggesting a possible role of glial cell pathologies in the development of FASD. However, the molecular mechanisms of neuron-glia interactions that lead to the development of FASD are not clearly understood. In this review, we discuss glial cell pathologies with a particular emphasis on microglia, primary resident immune cells in the brain. Additionally, we examine the involvement of several neuroimmune molecules released by glial cells, their signaling pathways, and epigenetic mechanisms responsible for FASD-related alteration in brain functions. Growing evidence suggests that extracellular vesicles (EVs) play a crucial role in the communication between cells via transporting bioactive cargo from one cell to the other. This review emphasizes the role of EVs in the context of neuron-glia interactions during prenatal alcohol exposure. Finally, some potential applications involving nutritional, pharmacological, cell-based, and exosome-based therapies in the treatment of FASD are discussed.

Peripheral and central macrophages in obesity.

Obesity is associated with chronic, low-grade inflammation. Excessive nutrient intake causes adipose tissue expansion, which may in turn cause cellular stress that triggers infiltration of pro-inflammatory immune cells from the circulation as well as activation of cells that are residing in the adipose tissue. In particular, the adipose tissue macrophages (ATMs) are important in the pathogenesis of obesity. A pro-inflammatory activation is also found in other organs which are important for energy metabolism, such as the liver, muscle and the pancreas, which may stimulate the development of obesity-related co-morbidities, including insulin resistance, type 2 diabetes (T2D), cardiovascular disease (CVD) and non-alcoholic fatty liver disease (NAFLD). Interestingly, it is now clear that obesity-induced pro-inflammatory signaling also occurs in the central nervous system (CNS), and that pro-inflammatory activation of immune cells in the brain may be involved in appetite dysregulation and metabolic disturbances in obesity. More recently, it has become evident that microglia, the resident macrophages of the CNS that drive neuroinflammation, may also be activated in obesity and can be relevant for regulation of hypothalamic feeding circuits. In this review, we focus on the action of peripheral and central macrophages and their potential roles in metabolic disease, and how macrophages interact with other immune cells to promote inflammation during obesity.

Quasi-Isomeric Anion-Templated Silver Nanoclusters: Effect of Bulkiness on Luminescence.

Anion-templated silver nanoclusters are fascinating to study because of their diverse structures, which are dictated by the nature of both anions and ligands. Here, we used the bulky 1-ethynyladamantane as one of the protecting ligands alongside trifluoracetate to successfully synthesize a chlorine-templated silver nanocluster─Cl@Ag19(C12H15)11(C2O2F3)7. Elucidation of its structure by single crystal X-ray diffraction revealed the structure to be a chlorine-centered Ag19 cage with protection by alkynyl and carboxylic ligands. This cluster is non-emissive at room temperature and showed green emission with a large Stokes shift at low temperature. The crystal structure was found to be quasi-isomeric with a previously reported Ag19 cluster protected by tert-butyl acetylene, which is emissive at room temperature. Detailed photoluminescence studies and structure-property correlation revealed that the arrangement of the silver skeleton which is influenced by the bulky substituent of the ligand might be responsible for the difference in emission properties.

Obesity wars: hypothalamic sEVs a new hope.

There are currently several pharmacological therapies available for the treatment of obesity, targeting both the central nervous system (CNS) and peripheral tissues. In recent years, small extracellular vesicles (sEVs) have been shown to be involved in many pathophysiological conditions. Because of their special nanosized structure and contents, sEVs can activate receptors and trigger intracellular pathways in recipient cells. Notably, in addition to transferring molecules between cells, sEVs can also alter their phenotypic characteristics. The purpose of this review is to discuss how sEVs can be used as a CNS-targeted strategy for treating obesity. Furthermore, we will evaluate current findings, such as the sEV-mediated targeting of hypothalamic AMP-activated protein kinase (AMPK), and discuss how they can be translated into clinical application.

Silver Nanoparticle-Incorporated Defect-Engineered Zr-based Metal-Organic Framework for Efficient Multicomponent Catalytic Reactions.

Small-sized silver nanoparticles are incorporated into a thiol-functionalized stable Zr-based metal-organic framework (MOF). Thiol functionalization has been carried out using 2-mercapto benzoic acid (2-MBA) as the modulator, which promotes defect formation in the MOF structure. The incorporation of silver nanoparticles aided by the silver-sulfur interactions in this defective MOF gives rise to catalytic activity. Its catalytic efficiency in the highly atom-efficient A3 coupling reaction has been studied for a variety of substrates with impressive recyclability. The synergistic effect of the electron-rich silver core and electron-deficient surface of the thiol-bonded silver nanoparticle is key for this catalytic reaction.

Co-reactant-Free Transformation in Atomically Precise Metal Nanoclusters.

Transformation chemistry has advanced significantly in recent years as an excellent methodology for synthesizing new nanoclusters and functionalizing the existing ones. However, rational synthesis and fundamental understanding of the structural evolution among clusters have not yet been achieved in nanocluster science. A deeper understanding of the fundamental aspects of structure-property correlation is necessary for the employment of befitting nanoclusters for specific applications. Very recently, the transformation of nanoclusters without the use of conventional co-reactants has been brought to light. These co-reactant-less transformations are triggered by various conditions, such as pH, solvent, light, temperature, etc. In this perspective, we discuss how this unique method of transformation without any co-reactant benefits the basic understanding of growth patterns and the corresponding property evolution in nanoclusters.

Gold Deassembly: From Au44(SPh-tBu)28 to Au36(SPh-tBu)24 Nanocluster through Dynamic Surface Structure Reconstruction.

Molecular level understanding of the structural growth patterns and property evolution in nanoclusters (NCs) is crucial for the design and rational synthesis of clusters for specific properties and applications. In this regard, transformation has always been a versatile approach to achieve atomic precision with atomic purity and a deeper understanding of the growth mechanisms of noble metal NCs. To the latter end, we have demonstrated a structural transformation of Au44(SPh-tBu)28 to Au36(SPh-tBu)24 NC, which occurred through the deassembly of an Au8(SPh-tBu)4 fragment. Kinetic studies conducted on the transformation showed that it follows zero-order kinetics with a low activation energy pathway. Theoretical studies demonstrated that this process happens via surface restructuring of the core-ligand interface, which was found to be the rate-determining step of this transformation. Based on this, a plausible mechanistic pathway for the transformation have been proposed which we envision, will provide useful insights into NC structure evolution.

Structural localization of pathogenic mutations in the central nucleotide-binding domain (NBD) of nucleotide-binding oligomerization domain-2 (NOD2) protein and their inference in inflammatory disorders.

The human NBD domain which is centrally located in the NOD2 protein displays an essential role in oligomerization and initiates the immune response via CARD-RIPK2 interaction. The mutations associated with the NBD domain have been largely implicated in inflammatory disorders such as Blau syndrome and sarcoidosis. This study aims to determine the structural and phenotypic effect of a lethal mutation that occurs in the NBD domain which has an axiomatic impact on protein dysfunction. Initially, the most deleterious missense mutations were screened through various in silico analysis. Out of 33 variants, I-Mutant 3.0, SIFT, PolyPhen 2, Align GVGD, PHD SNP and SNP&GO have statistically identified 5 variants (R42W, D90E, E91K, G189D & W198L) as less stable, deleterious and damaging. Our predicted models have paved the way to understand the various structural properties such as physiochemical, secondary structural arrangements and stabilizing residues in folding associated with the native and mutant NBD domain especially of the functionally important regions. From the aforementioned results, R42W and G189D were found to be the more predominant among the mutants. Precisely, through molecular simulation, we have strongly justified the significant conformational disruption of R42W and G189D through the stabilization factors, folding and essential dynamics. Conclusively, these regions (α341-44, α13185-191 and ß6133-143ß7) seem to adopt such structures that are not conducive to wild-type-like functionality. Our prediction and validation of lethal mutations based on structural stability may be useful for conducting experimental studies in detail to uncover the protein deregulation leading to inflammatory disorders.

Transcriptomic analysis of castration, chemo-resistant and metastatic prostate cancer elucidates complex genetic crosstalk leading to disease progression.

Prostate adenocarcinoma, with its rising numbers and high fatality rate, is a daunting healthcare challenge to clinicians and researchers alike. The mainstay of our meta-analysis was to decipher differentially expressed genes (DEGs), their corresponding transcription factors (TFs), miRNAs (microRNA) and interacting pathways underlying the progression of prostate cancer (PCa). We have chosen multiple datasets from primary, castration-resistant, chemo-resistant and metastatic prostate cancer stages for investigation. From our tissue-specific and disease-specific co-expression networks, fifteen hub genes such as ACTB, ACTN1, CDH1, CDKN1A, DDX21, ELF3, FLNA, FLNC, IKZF1, ILK, KRT13, KRT18, KRT19, SVIL and TRIM29 were identified and validated by molecular complex detection analysis as well as survival analysis. In our attempt to highlight hub gene-associated mutations and drug interactions, FLNC was found to be most commonly mutated and CDKN1A gene was found to have highest druggability. Moreover, from DAVID and gene set enrichment analysis, the focal adhesion and oestrogen signalling pathways were found enriched which indicates the involvement of hub genes in tumour invasiveness and metastasis. Finally by Enrichr tool and miRNet, we identified transcriptional factors SNAI2, TP63, CEBPB and KLF11 and microRNAs, namely hsa-mir-1-3p, hsa-mir-145-5p, hsa-mir-124-3p and hsa-mir-218-5p significantly controlling the hub gene expressions. In a nutshell, our report will help to gain a deeper insight into complex molecular intricacies and thereby unveil the probable biomarkers and therapeutic targets involved with PCa progression.

Understanding the Effects of Antipsychotics on Appetite Control.

Antipsychotic drugs (APDs) represent a cornerstone in the treatment of schizophrenia and other psychoses. The effectiveness of the first generation (typical) APDs are hampered by so-called extrapyramidal side effects, and they have gradually been replaced by second (atypical) and third-generation APDs, with less extrapyramidal side effects and, in some cases, improved efficacy. However, the use of many of the current APDs has been limited due to their propensity to stimulate appetite, weight gain, and increased risk for developing type 2 diabetes and cardiovascular disease in this patient group. The mechanisms behind the appetite-stimulating effects of the various APDs are not fully elucidated, partly because their diverse receptor binding profiles may affect different downstream pathways. It is critical to identify the molecular mechanisms underlying drug-induced hyperphagia, both because this may lead to the development of new APDs, with lower appetite-stimulating effects but also because such insight may provide new knowledge about appetite regulation in general. Hence, in this review, we discuss the receptor binding profile of various APDs in relation to the potential mechanisms by which they affect appetite.

Defects Engineering on Ceria and C-C Coupling Reactions Using [Au11(PPh3)7I3] Nanocluster: A Combined Experimental and Theoretical Study.

Ligand protected atom-precise gold-based catalysts have been utilized in many essential chemical processes, but their mechanism and the fate of the catalyst during reaction are still unrevealed. Atom-precise cluster without ligands are thus highly desirable to maximize atom efficiency, but making these in solution phase is challenging. In this scenario, catalysts with dispersion on oxide support are highly desirable to understand the role of metal core during catalytic reaction. Here, we report the synthesis of Au11(PPh3)7I3 cluster that consists of an incomplete icosahedron core. During its impregnation process on CeO2 support, all of the ligands were removed from the kernel and the Au11 kernel fits into the defects of ceria (embedded onto the oxygen vacancy of ceria (111) plane). This Au11@CeO2 has high atom efficiency and catalytic activity for Ullmann-type C-C homocoupling reactions for electron rich substrates. Density functional theory calculations showed that hexagonal arrangements of Au11 kernel on (111) plane of CeO2 is the most stable one. Theoretical calculations also proved that the atop gold atom has more favorable interaction with phenyl iodide than the second layer gold atoms of the Au11@CeO2. This demonstrated that the present catalyst mimics the single-atom catalyst-like behavior in facilitating the coupling reactions.

Alcohol Increases Exosome Release from Microglia to Promote Complement C1q-Induced Cellular Death of Proopiomelanocortin Neurons in the Hypothalamus in a Rat Model of Fetal Alcohol Spectrum Disorders.

Microglia, a type of CNS immune cell, have been shown to contribute to ethanol-activated neuronal death of the stress regulatory proopiomelanocortin (POMC) neuron-producing ß-endorphin peptides in the hypothalamus in a postnatal rat model of fetal alcohol spectrum disorders. We determined whether the microglial extracellular vesicle exosome is involved in the ethanol-induced neuronal death of the ß-endorphin neuron. Extracellular vesicles were prepared from hypothalamic tissues collected from postnatal rats (both males and females) fed daily with 2.5 mg/kg ethanol or control milk formula for 5 d or from hypothalamic microglia cells obtained from postnatal rats, grown in cultures for several days, and then challenged with ethanol or vehicle for 24 h. Nanoparticle tracking analysis and transmission electron microscopy indicated that these vesicles had the size range and shape of exosomes. Ethanol treatments increased the number and the ß-endorphin neuronal killing activity of microglial exosomes both in vivo and in vitro Proteomics analyses of exosomes of cultured microglial cells identified a large number of proteins, including various complements, which were elevated following ethanol treatment. Proteomics data involving complements were reconfirmed using quantitative protein assays. Ethanol treatments also increased deposition of the complement protein C1q in ß-endorphin neuronal cells in both in vitro and in vivo systems. Recombinant C1q protein increased while C1q blockers reduced ethanol-induced C3a/b, C4, and membrane attack complex/C5b9 formations; ROS production; and ultimately cellular death of ß-endorphin neurons. These data suggest that the complement system involving C1q-C3-C4-membrane attack complex and ROS regulates exosome-mediated, ethanol-induced ß-endorphin neuronal death.SIGNIFICANCE STATEMENT Neurotoxic action of alcohol during the developmental period is recognized for its involvement in fetal alcohol spectrum disorders, but the lack of clear understanding of the mechanism of alcohol action has delayed the progress in therapeutic intervention of this disease. Proopiomelanocortin neurons known to regulate stress, energy homeostasis, and immune functions are reported to be killed by developmental alcohol exposure because of activation of microglial immune cells in the brain. While microglia are known to use extracellular vesicles to communicate with neurons for maintaining homeostasis, we show here that ethanol exposure during the developmental period hijacks this system to spread apoptotic factors, including complement protein C1q, to induce the membrane attack complex and reactive super-oxygen species for proopiomelanocortin neuronal killing.

A novel nanoformulation of α-eleostearic acid restores molecular pathogenesis of hypersensitivity.

AIM: The present work provides first-time empirical and molecular interaction evidence to establish the higher biofunctionality of a therapeutic lipid, α-eleostearic acid (ESA), encapsulated in a novel and thoroughly characterized biocompatible nanoemulsion (NE) system (particle size <200 nm). MATERIALS & METHODS: A novel methodology was employed to fabricate novel formulations of ESA. Molecular biological tools and assays were used to arrive at definite conclusions. RESULTS: The proinflammatory profile was found to be significantly mitigated in the hypersensitized rats administered with the ESA-NE formulation more emphatically as compared with ESA-conventional emulsion in both in vivo and ex vivo models. CONCLUSION: The novel ESA-NE formulation shows a lot of palpable promise for clinical applications.

Early life alcohol exposure primes hypothalamic microglia to later-life hypersensitivity to immune stress: possible epigenetic mechanism.

Growing evidence has shown that developmental alcohol exposure induces central nervous system inflammation and microglia activation, which may contribute to long-term health conditions, such as fetal alcohol spectrum disorders. These studies sought to investigate whether neonatal alcohol exposure during postnatal days (PND) 2-6 in rats (third trimester human equivalent) leads to long-term disruption of the neuroimmune response by microglia. Exposure to neonatal alcohol resulted in acute increases in activation and inflammatory gene expression in hypothalamic microglia including tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6). Adults with neonatal alcohol pre-exposure (alcohol fed; AF) animals showed an exaggerated peripheral stress hormonal response to an immune challenge (lipopolysaccharides; LPS). In addition, there were significantly more microglia present in the hypothalamus of adult AF animals, and their hypothalamic microglia showed more cluster of differentiation molecule 11b (Cd11b) activation, TNF-α expression, and IL-6 expression in response to LPS. Interestingly, blocking microglia activation with minocycline treatment during PND 2-6 alcohol exposure ameliorated the hormonal and microglial hypersensitivity to LPS in AF adult animals. Investigation of possible epigenetic programming mechanisms by alcohol revealed neonatal alcohol decreased several repressive regulators of transcription in hypothalamic microglia, while concomitantly increasing histone H3 acetyl lysine 9 (H3K9ac) enrichment at TNF-α and IL-6 promoter regions. Importantly, adult hypothalamic microglia from AF animals showed enduring increases in H3K9ac enrichment of TNF-α and IL-6 promoters both at baseline and after LPS exposure, suggesting a possible epigenetic mechanism for the long-term immune disruption due to hypothalamic microglial priming.

Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?

BACKGROUND: Inflammatory bowel diseases (IBD), which include Crohn's disease and Ulcerative Colitis, are inflammatory autoimmune diseases which severely affect the quality of life. Till date, no long-lasting cure has been found for the disease and all the current treatment strategies are mainly focused on dampening the symptomatic inflammatory process that has certain side effects. In addition, a large number of patients remain refractory to conventional therapies. Mesenchymal stem cells (MSCs) can be looked upon as a biodrug to treat IBD owing to their immune-suppressive and regenerative capabilities. MSCs provide an advantage over the other widely used adult stem cells- hematopoietic stem cells in the aspects of lower side effects and enhanced tolerability. MSCs have had reasonable success thus far in clinical trials to treat IBD via systemic delivery as well as in local delivery (perianal Crohn's disease). OBJECTIVE: In order to optimize and standardize, MSC based therapy for IBD, a better understanding of cellular and molecular mechanisms of the therapeutic activities of MSCs, is extremely mandatory. There has been a plethora of publications in the last decade which elucidates the biologic rationale that makes MSC a promising therapeutic tool for IBD. Recent studies have witnessed a replacement of hypotheses regarding the mechanism of MSCs in curing IBD. The present review summarizes all these discussions, the results of the trials carried out to date and the future prospects in this field. CONCLUSION: Based on the current development of MSC-based clinical trials and the ever-increasing rate of in-vitro studies, with a purpose to unveil the mechanism of curative approach of these cells, MSC based therapy for IBD can be expected to achieve clinical relevance in the near future.

AIEE phenomenon: tetraaryl vs. triaryl pyrazoles.

Tetraarylpyrazoles are synthesized from commercially available materials in three steps and found to exhibit Aggregation Induced Emission Enhancement (AIEE) characteristics. Removing one aryl unit from tetraarylpyrazole leads to Aggregation Caused Quenching (ACQ), thus the number of aryl groups plays an important role in exploring such a phenomenon.

Comparative real-time study of cellular uptake of a formulated conjugated linolenic acid rich nano and conventional macro emulsions and their bioactivity in ex vivo models for parenteral applications.

The objective of the present study was to fabricate and monitor real-time, impact of a stable conjugated linolenic acid, α-eleostearic acid (ESA) rich nanoemulsion (NE) formulation (d < 200 nm) vis-à-vis ESA conventional emulsion (CE) system in ex vivo systems against both endogenous and exogenous reactive oxygen species (ROS). Accordingly, stable nanoemulsion formulation of ESA was engineered with the aid of bitter melon seed oil and non-toxic excipients. Morphology and particle size of the emulsion formulations were studied to validate stability. The real-time rapid uptake of the ESA NE and its increased prophylactic efficacy against induced endogenous and exogenous ROS in terms of cell viability and membrane integrity was evaluated flow-cytometrically and with fluorescence microscopic analysis of different primary cells. It was found that the fabricated non-toxic ESA NE had stable parameters (hydrodynamic mean diameter, particle size distribution and zeta potential) for over 12 weeks. Further, ESA NE at a concentration of ∼ 70 µM exhibited maximum efficacy in protecting cells from oxidative damage against both endogenous and exogenous ROS in lymphocytes and hepatocytes as compared to its corresponding presence in the CE formulation. This study provides a real-time empirical evidence on the influence of nano formulation in enhancing bioavailability and antioxidative properties of ESA.

Exploration of novel rhizospheric yeast isolate as fertilizing soil inoculant for improvement of maize cultivation.

BACKGROUND: Chemical input in agriculture is a common practice but makes a serious impact to the environment. In this context, soil isolates having multiple plant growth-promoting (PGP) attributes have been studied. The isolates were tested for their PO4 and Zn solubilization, indole-3-acetic acid (IAA) production and N2 fixation ability. The selected isolate SSm-39 was characterized to molecular level. The isolate SSm-39 was applied to maize cultivation in various combinations with chemical fertilizers. Also, the chemical and microbial status of soil, its effect on maize growth and yield were investigated. RESULTS: Isolate SSm-39 found most suitable for its PGP attributes and identified as Candida tropicalis. The inoculant (100%) with reduced dose of chemical fertilizer (T5) application notably increased the growth and yield performance of maize. It has improved grain quality by 85% as indicated by carbohydrate and protein content, in comparison to uninoculated control (T3). Soil nutrient status was found to increase twofold with T5 treatment compared with T3 treatment. Enhanced soil nutrient quality supported microbial growth and diversity, thus accelerating soil enzymatic activities. CONCLUSION: The results validate the multiple PGP traits of C. tropicalis SSm-39, advocating reduction of chemical fertilizer for maize cultivation.

Comparative prophylactic effects of α-eleostearic acid rich nano and conventional emulsions in induced diabetic rats.

The present work entailed perspicacious fabrication of Bitter Gourd Seed Oil Nanoemulsion (BGO-NE) for increasing bioavailability of CLnA in oxidative stress induced in vivo system. The BGO-NE was characterized and evaluated for dimensional as well as rheological changes periodically during a 12 week storage period. BGO comprising ∼50 % α-eleostearic acid, was assessed in conventional and NE formulation at different doses, for its ability to stimulate antioxidative enzyme marker paradigm comprising SOD, GPx, CAT and GSH, inherent to the subjects under study. The formulated BGO-NE (d < 100 nm) was found to be stable for 12 weeks compared to BGO-CE as was determined by particle size characterization and associated parameters. Diet supplementation of 0.5 % (w/v) BGO-NE formulation exhibited maximum efficiency in countering oxidative stress as compared to 1 % BGO-NE formulation and equivalent doses of BGO-CE. Higher efficacy at very low dose of the nano-sized formulation was thus, also established. Histopathological data from liver, pancreas and kidney sections corroborated the above findings. The present study with formulated BGO-NE and BGO-CE evaluates and confirms the implications of a NE formulation of a bioactive lipid - conjugated linolenic acid (CLnA), targeting specific in vivo processes to counter the negative influence of excess ROS (Reactive Oxygen Species) in the system. It, thus presents itself as a potent nutraceutical against diabetes mellitus in an optimized delivery system.

Environmentally benign synthesis and antimicrobial study of novel chalcogenophosphates.

We report in this work an environmentally benign zinc mediated synthesis of aryl and benzyl phosphorochalcogenoates in ethanol within a short reaction time. In vitro antimicrobial study along with statistical analysis and seed germination assay were performed. These chalcogenophosphates possess strong antimicrobial activity against the reference strains. The antibacterial activity was determined against four standard strains (Bacilus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa). The antifungal activity was evaluated against one fungal strain Candida albicans.